Infectious Disease and Microbiology – Toxic shock syndrome

Toxic shock syndrome (TSS) is a severe toxin-mediated illness caused mainly by Staphylococcus aureus or Streptococcus pyogenes. It typically presents with abrupt fever, hypotension, diffuse erythematous rash, and rapidly progressive multiorgan dysfunction. Gastrointestinal symptoms, severe myalgias, mucosal hyperemia, renal or hepatic dysfunction, thrombocytopenia, and altered mental status may occur, while desquamation of the palms and soles often develops during convalescence.

Epidemiology

Staphylococcal TSS is uncommon, with an estimated incidence of roughly 1–3 cases per 100,000 people, whereas streptococcal TSS is also rare but generally carries a higher mortality.

Approximately half of staphylococcal TSS cases have historically occurred in menstruating women using tampons, although nonmenstrual disease occurs in people of all ages and sexes.

Streptococcal TSS most often accompanies invasive soft-tissue infection, particularly necrotizing fasciitis, myonecrosis, or severe cellulitis.

Risk factors

Important risk factors for staphylococcal TSS include tampon use, barrier contraceptive devices, postpartum infection, septic abortion, gynecologic procedures, surgical wounds, burns, nasal packing, skin infections, bacteremia, and musculoskeletal infections.

Risk factors for streptococcal TSS include minor trauma, open wounds, surgery, varicella, invasive group A streptococcal infection, and close contact with a person who has invasive streptococcal disease.

Pathophysiology

TSS is caused by bacterial toxins that act as superantigens.

These toxins bypass conventional antigen processing and directly activate large populations of T lymphocytes, producing massive release of inflammatory cytokines such as tumor necrosis factor, interleukin-1, and interleukin-6.

The resulting cytokine surge causes high fever, profound vasodilation, capillary leakage, hypotension, shock, and tissue injury.

In menstrual staphylococcal TSS, tampons can provide a local environment that promotes colonization and toxin production by S. aureus.

Etiology

Most cases of staphylococcal TSS are associated with S. aureus strains producing toxic shock syndrome toxin-1 (TSST-1).

Other staphylococcal enterotoxins can occasionally produce a similar syndrome.

For disease to develop, the patient generally must be colonized or infected with a toxigenic strain and lack sufficient neutralizing antibodies against its toxin.

Streptococcal TSS is caused by invasive Streptococcus pyogenes infection, with production of streptococcal pyrogenic exotoxins and other virulence factors.

Clinical presentation

TSS develops rapidly over hours to a few days.

Patients usually present with high fever, hypotension, diffuse erythematous rash, vomiting, diarrhea, severe myalgia, weakness, and signs of multiorgan involvement.

Shock can progress rapidly and may require substantial fluid resuscitation and vasopressor support.

Staphylococcal toxic shock syndrome

The classic presentation includes a temperature of at least approximately 38.9°C, diffuse macular erythroderma, and hypotension.

At least several organ systems are usually involved.

Gastrointestinal manifestations commonly include vomiting and diarrhea at the onset of illness.

Muscle involvement is characterized by severe myalgia or elevated creatine kinase.

Mucosal involvement can produce conjunctival, oral, pharyngeal, or vaginal hyperemia.

Renal involvement may present with elevated creatinine or pyuria, while hepatic involvement causes elevated bilirubin or aminotransferases.

Thrombocytopenia is common.

Neurologic manifestations may include confusion or disorientation without focal neurologic signs.

A diffuse “sunburn-like” rash is characteristic, followed approximately one to two weeks later by desquamation, particularly of the palms and soles.

An obvious focus of infection is often absent in staphylococcal TSS.

Streptococcal toxic shock syndrome

Streptococcal TSS is usually associated with a clear invasive focus such as necrotizing fasciitis, myositis, cellulitis, or another deep soft-tissue infection.

Diagnosis is supported by identification of group A streptococcus from a sterile or clinically relevant site together with hypotension and evidence of multiorgan dysfunction.

Organ involvement may include acute kidney injury, coagulopathy or DIC, hepatic injury, acute respiratory distress syndrome, generalized erythematous rash, and soft-tissue necrosis.

Bacteremia occurs much more frequently in streptococcal TSS than in staphylococcal TSS.

Physical examination

The most prominent finding in staphylococcal TSS is often a diffuse erythematous macular rash.

Desquamation is a delayed finding and usually does not help with the earliest diagnosis.

In menstruating patients with possible TSS, a gynecologic examination is important, and any tampon or vaginal foreign body should be removed immediately.

Patients with streptococcal TSS should be carefully examined for a source of invasive infection, including painful swollen soft tissues, bullae, skin discoloration, crepitus, rapidly spreading erythema, or pain out of proportion to visible findings.

Laboratory findings

Laboratory abnormalities reflect systemic inflammation and multiorgan injury.

Common findings include leukocytosis or leukopenia with a left shift, thrombocytopenia, azotemia, elevated creatine kinase, hypoalbuminemia, hypocalcemia, hypophosphatemia, pyuria, elevated liver enzymes, and metabolic abnormalities associated with shock.

Blood cultures should be obtained in all suspected cases to evaluate for bacteremia and alternative causes such as meningococcemia or gram-negative sepsis.

Blood cultures are often negative in staphylococcal TSS but are positive in a substantial proportion of streptococcal TSS cases.

Cultures should also be obtained from any suspected wound, soft-tissue infection, vaginal source, surgical site, or other focus.

Differential diagnosis

Important alternatives include meningococcemia, severe gram-negative sepsis, Rocky Mountain spotted fever, leptospirosis, measles, Kawasaki disease, heat stroke, severe drug reactions, and other causes of distributive shock with rash.

Necrotizing soft-tissue infection must be considered particularly when the patient has severe focal pain, rapidly progressive swelling, tissue necrosis, or crepitus.

Initial treatment

TSS is a medical emergency requiring immediate resuscitation, broad antimicrobial therapy, and urgent source control.

Treatment should not be delayed while waiting for definitive culture results.

Staphylococcal TSS treatment

Empiric treatment should cover MRSA and suppress toxin production.

A typical initial regimen includes vancomycin plus clindamycin.

Clindamycin is especially valuable because it suppresses bacterial protein synthesis and therefore decreases toxin production.

If cultures identify methicillin-susceptible S. aureus, therapy can be narrowed to an antistaphylococcal β-lactam such as nafcillin or oxacillin, while continuing clindamycin during the acute toxin-mediated phase.

Linezolid is another potential toxin-suppressing anti-MRSA agent in selected cases.

Streptococcal TSS treatment

The preferred regimen is high-dose intravenous penicillin G plus clindamycin.

Penicillin provides potent bactericidal activity against group A streptococcus, while clindamycin reduces toxin synthesis and remains active even when bacterial burden is high.

Antimicrobial treatment is subsequently adjusted according to microbiology, clinical response, and the extent of associated infection.

Source control

Source control is essential and should occur as early as possible.

Any tampon, vaginal device, nasal packing, infected catheter, or other foreign material should be removed.

Abscesses should be drained.

Patients with necrotizing fasciitis or myonecrosis require immediate surgical exploration and aggressive debridement, often with repeated operations.

Delay in surgical treatment of invasive streptococcal infection significantly worsens outcome.

Hemodynamic support

Most patients require admission to the intensive care unit.

Large-volume isotonic intravenous fluid resuscitation is frequently necessary because profound capillary leakage and vasodilation can cause severe intravascular depletion.

If hypotension persists despite fluids, vasopressors are required.

Respiratory support, including mechanical ventilation, may be necessary in patients with ARDS or severe shock.

Intravenous immunoglobulin

IVIG may be considered in severe streptococcal TSS, particularly when shock or invasive soft-tissue disease is refractory to standard therapy.

Its proposed benefit comes from neutralization of circulating exotoxins and superantigens.

Evidence is less certain for staphylococcal TSS, although IVIG may occasionally be considered in exceptionally severe cases.

Routine corticosteroid treatment is not established for TSS.

In-patient considerations

Patients with suspected TSS should be treated in the ICU because deterioration can occur rapidly.

Continuous monitoring of blood pressure, urine output, oxygenation, renal function, hepatic function, platelet count, coagulation parameters, and metabolic status is required.

Discharge is appropriate only after the patient is afebrile, hemodynamically stable without vasopressors, clinically improving, and no longer requires intensive supportive therapy.

Follow-up

Patients recovering from staphylococcal TSS may benefit from evaluation for S. aureus colonization.

In selected patients with persistent nasal carriage, intranasal mupirocin and other decolonization measures may be considered.

Staphylococcal TSS can recur, particularly when the patient remains colonized with a toxin-producing strain and does not develop protective antibodies.

Women who have experienced menstrual TSS should generally avoid tampons and certain intravaginal barrier contraceptive devices, particularly if the risk of recurrence remains high.

Household contacts of patients with invasive streptococcal TSS do not routinely require prophylaxis, although prophylaxis may be considered for particularly vulnerable close contacts such as older adults or those with significant immunocompromise.

Prognosis

Staphylococcal TSS generally has a lower mortality than streptococcal TSS when recognized and treated promptly.

Most deaths occur early and are related to refractory shock and multiorgan failure.

Streptococcal TSS has a substantially worse prognosis because it is often accompanied by bacteremia and destructive invasive soft-tissue infection.

Complications

TSS can cause profound shock with secondary injury to virtually every organ system.

Major complications include acute respiratory distress syndrome, acute kidney injury, disseminated intravascular coagulation, hepatic dysfunction, encephalopathy, myocardial dysfunction, ischemic injury, and multiorgan failure.

Severe invasive streptococcal disease can additionally result in extensive tissue necrosis, limb loss, and death.

High-Yield Pattern

Fever + diffuse sunburn-like rash + hypotension + multiorgan dysfunction → suspect toxic shock syndrome

Menstruating patient using tampon + shock + erythroderma → strongly consider staphylococcal TSS

Severe soft-tissue pain + hypotension + organ failure → suspect streptococcal TSS and necrotizing infection

Staphylococcal TSS → vancomycin + clindamycin initially

Streptococcal TSS → penicillin G + clindamycin

Any TSS → immediate source control + aggressive fluids + vasopressors when needed

Necrotizing soft-tissue infection → urgent surgical exploration and debridement